ETFMG Treatments, Testing and Advancements ETF — new fund registration

ETF Managers Trust registered 1 new fund series on Form 485APOS, filed 2020-04-24. Featured series: ETFMG Treatments, Testing and Advancements ETF.

Registration

Registrant / trust: ETF Managers Trust
CIK: 0001467831
Form: 485APOS
Filed: 2020-04-24
State of incorporation: DE
Accession: 0000894189-20-002933
Reported net assets: $12.8M

Series & classes (1)

Series	Class	Ticker	New
ETFMG Treatments, Testing and Advancements ETF	ETFMG Bio ETF	—	Yes

Fees (from the effective prospectus)

12b-1 fee: 0.00%
Gross expense ratio: 0.68%
Management fee: 0.68%
Other expenses: 0.00%

Investment objective

The ETFMG Treatments, Testing and Advancements ETF (the Fund or the Treatments ETF) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index (the Index).

Advisers

ETF Managers Group LLC (Advisor)